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CHAPTER-I 
INTRODUCTION 
 
 Bronchiectasis is one of the most common diseases in the rural and industrial 
areas of India. There are reports of high prevalence in relatively isolated populations with 
poor access to health care and high rates of respiratory tract infections during childhood. 
Bronchiectasis is an abnormal dilatation of the bronchi associated with obstruction and 
infection. Clinically, Bronchiectasis is defined as an abnormal dilatation of medium size 
bronchi and bronchioles (about the fourth to ninth generations), generally associated with 
previous, chronic necrotizing infections within these passages. The etio-pathogenesis of 
Bronchiectasis is related to bronchial obstructions, infections or both in a large majority 
of patients. The condition most commonly affects the lower lobes, the lingula and then 
the middle lobe.It tends to affect the left lung more than right, although 50% of cases are 
bilateral.It is an uncommon disease with the potential to cause devastating illness 
including repeated respiratory infections requiring antibiotics, disabling productive 
cough, shortness of breath, and occasional haemoptysis. 
 
Typical signs and symptoms include; Sputum overproduction, Fever, Pleurisy, 
Dyspnoea, Chronic cough, Haemoptysis, Added sounds, Clubbing. Pulmonary function 
test of patients with localized bronchiectasis show reduction in FEV1, maximal mid 
expiratory flow rate, Maximal voluntary ventilation (MVV), diffusing capacity and 
increase in residual volume. Spirometry often shows a limitation of airflow with a 
reduced ratio of forced expiratory volume in one second (FEV1) to forced vital capacity 
(FVC), a normal or slightly reduced FVC, and a reduced FEV1. A reduced FVC may 
indicate that airways are blocked by mucus, which collapse with forced exhalation or 
there is pneumonitis in the lung. High-resolution CT has become the best tool for 
diagnosing bronchiectasis, clarifying the findings from chest radiography and mapping 
airway abnormalities that cannot be seen on plain films of the chest. The invention of 
Broad spectrum antibiotics in this era has lessened the mortality and morbidity rate in 
respiratory infective diseases. The most accepted treatment protocol preferred for 
Bronchiectasis now days includes oral, aerosolized or intravenous antibiotic therapy 
according to the severity of the exacerbation and mucus clearance by means of bronchial 
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hygiene assistive devices, surgical resection, chest physiotherapy like breathing exercises, 
postural drainage, high-frequency chest compression, forced expiratory techniques etc 
Enhancing the removal of respiratory secretions in patients with bronchiectasis is 
beneficial.Physical means such as gravitational postural drainage and the forced 
expiration technique (FET) used for chest physiotherapy may also be effective. In 
addition to the control of cough, postural drainage, chest physiotherapy, thinning and 
loosening of secretions, the administration of a bronchodilator and of inhaled 
corticosteroids has been a part of maintenance therapy and treatment for acute 
exacerbations. ACBT could an effective method of airway clearance technique in 
Bronchiectasis and it is effective in cleaning secretions and improving lung functions. 
These techniques can be used in stable COPD patients according to the patient‟s and the 
Physiotherapist‟s preferences. 
Pulmonary Function Test, Oxygen saturation and Peak Expiratory Flow Rate can 
measure the effects of postural drainage and Active Cycle of Breathing Techniques. 
Monitoring Pulmonary Function Test provides a guide to the state and function of the 
respiratory system. It indicates the Forced Expiratory Volume in one second (FEV1), 
Vital capacity, Forced Vital Capacity, the Peak Expiratory Flow Rate and oxygen 
saturation (SPO2) which are used as means of monitoring the effects of postural drainage 
and active cycle of breathing techniques in bronchiectasis.There is not enough evidence 
to support or refute the use of bronchial hygiene physical therapy in patients with chronic 
obstructive pulmonary disease and bronchiectasis. Considering the above factors, the 
need arises to examine the effects of broncho-pulmonary hygiene physical therapy and to 
compare the efficacy of Active cycle of breathing technique versus Postural drainage in 
the management of patients with bronchiectasis to know which technique is more 
effective for patients with Bronchiectasis. 
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1.1 ANATOMY 
Bronchiectasis is a disease in which there is permanent enlargement of parts of the 
airways of the lung. Symptoms typically include a chronic cough productive of mucus. 
Other symptoms include shortness of breath, coughing up blood and chest pain. 
Wheezing and nail clubbing may also occur. Those with the disease often get frequent 
lung infections. 
Bronchiectasis may result from a number of infective and acquired causes, 
including pneumonia, tuberculosis, immune system problems, and cystic fibrosis. Cystic 
fibrosis eventually results in severe bronchiectasis in nearly all cases. The cause in 10-
50% of those without cystic fibrosis is unknown. The mechanism of disease is breakdown 
of the airways due to an excessive inflammatory response. Involved bronchi become 
enlarged and thus less able to clear secretions. These secretions increase the amount of 
bacteria in the lungs, result in airway blockage and further breakdown of the airways. It is 
classified as an obstructive lung disease, along with Chronic obstructive pulmonary 
disease and Asthma. The diagnosis is suspect based on a person's symptoms and 
confirmed using computed tomography. Sputum cultures may be useful to determine 
treatment in those who have acute worsening and at least once a year. 
Worsening may occur due to infection and in these cases antibiotics are 
recommended. Typical antibiotics used include amoxicillin and in those who are allergic 
erythromycin or doxycycline. Antibiotics may also be used to prevent worsening of 
disease. Airway clearance techniques, postural drainage are recommended. Medications 
to dilate the airways may be useful in some but the evidence is not very good. The use of 
inhaled steroids have not been found to be useful. Surgery, while commonly done, has not 
been well studied. Lung transplantation may be an option in those with very severe 
disease. While the disease may cause significant health problems many other people with 
the disease do well. 
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Fig 1 ANATOMY OF BRONCHIECTASIS 
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1.2 EPIDEMIOLOGY  
In the United Kingdom the disease affects about 1 per 1000 adults. The disease is 
more common in male and increases as people age. It was first described by RENE 
LAENNEC in 1819.  
1.3 PATHOPHYSIOLOGY 
Bronchiectasis is a result of chronic inflammation compounded by an inability to 
clear mucoid secretions. This can be a result of genetic conditions resulting in a failure to 
clear sputum (primary ciliary dyskinesia), or resulting in more viscous sputum (cystic 
fibrosis), or the result of chronic or severe infections. Inflammation results in progressive 
destruction of the normal lung architecture, in particular the elastic fibres of bronchi. 
Endobronchial tuberculosis commonly leads to bronchiectasis, either from 
bronchial stenosis or secondary traction from fibrosis. 
 
Diagnostic Tests and Procedures 
Chest CT Scan 
This painless test creates precise pictures of your airways and other structures in 
your chest. A chest CT scan can show the extent and location of lung damage.  
Chest X Ray 
This painless test creates pictures of the structures in your chest, such as your 
heart and lungs. A chest x ray can show areas of abnormal lung and thickened, irregular 
airway walls. 
Other Tests 
 Blood tests.  
These tests can show whether you have an underlying condition that can lead to 
bronchiectasis. Blood tests also can show whether you have an infection or low levels of 
certain infection-fighting blood cells. 
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 Sputum culture.  
Lab tests can show whether a sample of your sputum contains bacteria (such as 
the bacteria that cause tuberculosis) or fungi. 
 Lung function tests.  
These tests measure how much air you can breathe in and out, how fast you can 
breathe air out, and how well your lungs deliver oxygen to your blood. Lung function 
tests help show how much lung damage you have. 
 A sweat test or other tests for cystic fibrosis. 
Bronchoscopy 
Bronchoscopy, a flexible tube with a light on the end is inserted through your nose 
or mouth into your airways. The tube is called a bronchoscope. It provides a video image 
of your airways. Bronchoscopy can show whether you have a blockage in your airways. 
The procedure also can show the source of any bleeding in your airways. 
 
1.4  SIGNS AND SYMPTOMS 
 Chronic Coughing. 
 Coughing up blood. 
 Abnormal Sounds or Wheezing in the Chest on Breathing. 
 Shortness of Breath. 
 Chest Pain. 
 Coughing up large amounts of Mucus daily. 
 Bad Breath Odour. 
 Skin with a blue appearance. 
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1.5  AETIOLOGY 
Bronchiectasis has both congenital and acquired causes, with the latter more 
frequent.  
Acquired causes 
Bronchiectasis secondary to a large carcinoid tumor (not shown) that was 
completely obstructing the bronchus proximally. The yellowish discoloration of lung 
parenchyma reflects obstructive pneumonia. 
Tuberculosis, pneumonia, inhaled foreign bodies, allergic broncho pulmonary 
aspergillosis and bronchial tumours are the major acquired causes of bronchiectasis. 
  Infective causes associated with bronchiectasis include infections caused by 
theStaphylococcus, Klebsiella or Bordetella pertussis, the causative agent of whooping 
cough.  
Aspiration of ammonia and other toxic gases, pulmonary 
aspiration, alcoholism, heroin (drug use), various allergies all appear to be linked to the 
development of bronchiectasis. 
    Various immunological and lifestyle factors have also been linked to the 
development of bronchiectasis. 
 Childhood Acquired Immune Deficiency Syndrome (AIDS), which predisposes 
patients to a variety of pulmonary ailments, such as pneumonia and 
other opportunistic infections.  
 Inflammatory bowel disease, especially ulcerative colitis. It can occur in Crohn's 
disease as well, but does so less frequently. Bronchiectasis in this situation usually 
stems from various allergic responses to inhaled fungal spores. A Hiatal hernia can 
cause Bronchiectasis when the stomach acid that is aspirated into the lungs causes 
tissue damage. 
 Rheumatoid arthritis suffers who smoke appear to have a tenfold 
increased prevalence of the disease. Still, it is unclear as to whether or not cigarette 
smoke is a specific primary cause of bronchiectasis. 
No cause is identified in up to 50% of non-cystic-fibrosis related bronchiectasis.  
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Congenital causes 
Bronchiectasis may result from congenital infections that affect cilia motility 
or ion transport. 
  Kartagener syndrome is one such disorder of cilia motility linked to the 
development of bronchiectasis. 
  A common cause is cystic fibrosis, which affects chloride ion transport in which a 
small number of patients develop severe localized bronchiectasis. 
  Young's syndrome, which is clinically similar to cystic fibrosis is thought to 
significantly contribute to the development of bronchiectasis. This is due to the 
occurrence of chronic infections of the sinuses and bronchiole tree.  
Other less-common congenital causes include primary immuno deficiencies due to 
the weakened or non-existent immune system response to severe, recurrent infections that 
commonly affect the lung. 
 Several other congenital disorders can also lead to bronchiectasis, 
including Williams-Campbell syndrome and Marfan syndrome. Patients with alpha 1-
antitrypsin deficiency have been found to be particularly susceptible to bronchiectasis for 
unknown reasons.  
 
1.6 OPERATIONAL DEFINITIONS 
BRONCHIECTASIS 
Bronchiectasis (brong-ke-EK-ta-sis) is a condition in which damage to the airways 
causes them to widen and become flabby and scarred. 
ACTIVE CYCLE OF BREATHING TECHNIQUE 
The Active Cycle of Breathing Techniques (ACBT) is a set of breathing exercises 
that loosens and clears the sputum from your airways.  The ACBT exercises are breathing 
control, deep breathing and huffing which are performed in a cycle. 
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POSTURAL DRAINAGE 
Postural drainage is used to treat breathing problems due to swelling and too much 
mucus in the airways of the lungs.Postural drainage, helps drain fluid out of the lungs. It 
helps to treat or prevent an infection. 
PULMONARY FUNCTION TEST 
Pulmonary function tests are a group of tests that measure how well the lungs take 
in and release air and how well they move gases such as oxygen from the atmosphere in 
to the body's circulation. 
PULSE OXYMETRY 
Pulse oxymetry is a noninvasive method for monitoring a person's oxygen 
saturation (SpO2). 
1.7 NEED FOR THE STUDY  
Bronchiectasis is one of the most common diseases in the rural and 
industrial areas of India. The most accepted treatment protocol preferred for 
Bronchiectasis now a days includes oral, aerosolized or intravenous antibiotic 
therapy according to the severity of the exacerbation and mucus clearance by means 
of bronchial hygiene assistive devices, surgical resection, chest physiotherapy like 
breathing exercises, postural drainage, high-frequency chest compression, forced 
expiratory techniques etc. Active cycle of breathing techniques (ACBT) is also the 
standard airway clearance technique used in patients with bronchiectasis. So this 
study is intended to know and compare the effectiveness of ACBT and Postural 
drainage techniques as a means of treatments in patients with bronchiectasis . 
 
1.8 AIM OF THE STUDY 
 The Aim of this study is to compare the effectiveness of ACBT and Postural 
drainage techniques as a means of treatments in patients with bronchiectasis. 
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1.9 OBJECTIVES OF THE STUDY 
 To have in-depth knowledge in bronchiectasis  patients. 
 
 To improve the quality of life in patients with bronchiectasis. 
 
 To find out the effectiveness of ACBT in improving the airway clearance 
in patients with bronchiectasis. 
 
 To find out the effectiveness of Postural drainage in improving the airway 
clearance in patients with bronchiectasis. 
 
 To compare the effectiveness of ACBT and Postural drainage in improving 
the airway clearance in patients with bronchiectasis. 
 
1.10 HYPOTHESIS 
1.10 (a). NULL HYPOTHESIS 
 There is no significant difference in between the effect of ACBT and 
Postural drainage in improving the airway clearance in patients with 
bronchiectasis. 
 
1.10 (b).  ALTERNATE HYPOTHESIS 
 There is significant difference between the effect of ACBT  andPostural 
drainage in improving the airway clearance in patients with bronchiectasis. 
 
1.11  ASSUMPTION 
 The study had been conducted assuming that  ACBT  and Postural 
drainage will  improves the airway clearance in patients with 
bronchiectasis. 
 
1.12  PROJECTED OUTCOME 
 Based on the  Review of literature the outcome of my study will be that 
both ACBT  and Postural drainage will  improves the airway clearance in 
patients with bronchiectasis. Further ACBT is more effective in improving 
the airway clearance in patients with bronchiectasis. 
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CHAPTER-2 
REVIEW OF LITERATURE 
1. Ada Clarice Gastaldi, PhD, Paolo Paredi, MD, AnjanaTalwar, MD, Sally Meah, 
Peter J. Barnes, and Omar S. Usmani, MD LeventDalar. (2015) 
This study aims to evaluate the acute effects of an oscillating positive expiratory 
pressure device (flutter) on airways resistance in patients with chronic obstructive 
pulmonary disease (COPD). 15 COPD outpatients  with thirty minutes of flutter 
exercises: a “flutter-sham” procedure was used as a control, and airway responses after a 
short-acting bronchodilator were also assessed. The use of flutter can decrease the 
respiratory system resistance and reactance and expiratory flow limitation in stable COPD 
patients with small amounts of secretions. 
2. EleonoraVolpato, Paolo Banfi, Sheena Michelle Rogers, and Francesco Pagnini 
(2015) 
This meta-analysis aimed to assess evidence from the scientific literature on the 
effects of relaxation techniques, investigated 9 databases to select 25 RCTs. The assessed 
quality of the studies, based on the Pedro Scale, was generally medium/high. Relaxation 
training can have a moderate impact on both psychological well-being and respiratory 
function, resulting in noticeable improvements in both. Although higher quality research 
is required, our results sustain the importance of relaxation techniques as a tool to manage 
COPD. 
3.Warnock L, Gates A (2015)  
  This author conducted study of Chest physiotherapy compared to no 
chest physiotherapy for cystic fibrosis. Chest physiotherapy is widely used in people with 
cystic fibrosis in order to clear mucus from the airways. To determine the effectiveness 
and acceptability of chest physiotherapy compared to no treatment or spontaneous cough 
alone to improve mucus clearance in cystic fibrosis The results of this review show that 
airway clearance techniques have short-term effects in the terms of increasing mucus 
transport. 
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4. Wei-jie Guan, Yong-hua Gao, Hui-min Li, Jing-jing Yuan, Rong-chang Chen,, 
and Nan-shanZhong, James D. Chalmers (2015)  
In this 148 consecutive adults with clinically stable bronchiectasis. CRS 
diagnosed based on the 2012 EP3OS criteria, systematically evaluated the bronchiectasis 
etiology, radiology, lung function, sputum bacteriology, airway inflammatory biomarkers, 
Bronchiectasis Severity Index, cough sensitivity and healthcare resource utilization. All 
patients were prospectively followed-up for 1 year to examine the frequency of 
bronchiectasis exacerbations (BEs); findings may be of clinical significance in that proper 
treatment of upper airway symptoms due to CRS will be theprevention of infection or re-
infection of the tracheobronchial tree, which should be addressed for the future 
management of bronchiectasis 
5. BR McCurdy (2014) 
This project emerged from a request by the Health System Strategy Division of 
the Ministry of Health and Long-Term Care that MAS provide them with an evidentiary 
platform on the effectiveness and cost-effectiveness of COPD interventions.After an 
initial review of health technology assessments and systematic reviews of COPD 
literature, and consultation with experts, MAS identified the following topics for analysis: 
vaccinations (influenza and pneumococcal), smoking cessation, multidisciplinary care, 
pulmonary rehabilitation, long-term oxygen therapy, noninvasive positive pressure 
ventilation for acute and chronic respiratory failure, hospital-at-home for acute 
exacerbations of COPD, and telehealth (including telemonitoring and telephone support). 
In addition, a review of the qualitative literature on patient, caregiver, and provider 
perspectives on living and dying with COPD was conducted. 
 
 
13 
 
6. James D. Chalmers, Pieter Goeminne, Stefano Aliberti, Melissa J. 
McDonnell, Sara Lonni, John Davidson,LucyPoppelwell, Waleed Salih, Alberto 
Pesci, Lieven J. Dupont, Thomas C. Fardon, Anthony De Soyza, and Adam T. Hill 
(2014) 
It describes the derivation and validation of the Bronchiectasis Severity Index 
(BSI). Derivation of the BSI used data from a prospective cohort study (Edinburgh, UK, 
2008–2012) enrolling 608 patients. In the validation cohorts, the AUC for mortality 
ranged from 0.81 to 0.84 and for hospitalization from 0.80 to 0.88. The BSI is a useful 
clinical predictive tool that identifies patients at risk of future mortality, hospitalization, 
and exacerbations across healthcare systems 
7.Huber LC, Bürgi U, Schuurmans MM, Benden C (2014)  
They conducted a study of Non-cystic fibrosis bronchiectasis: diagnosis and 
treatment. Bronchiectasis is the term used for irreversibly dilated airways.But the 
morphological findings are increasingly detected and the associated syndrome is more 
frequently diagnosed.Chronic infection with Pseudomonas aeruginosa is associated with a 
severe course of the disease and its detection has impacts on the therapeutic management.  
8. AntonelloNicolini, Federica Cardini, Norma Landucci, Sergio Lanata, Maura 
Ferrari-Bravo, and Cornelius Barlascini. (2013) 
High-frequency airway clearance (HFCWC) assist devices generate either positive 
or negative trans-respiratory pressure excursions to produce high-frequency, small-
volume oscillations in the airways. 37 patients were enrolled;10 patients treated with 
HFCWO by using the Vest® Airway Clearance System;10 patients treated with 
traditional techniques of air way clearance (PEP bottle, PEP mask, ELTGOL, vibratory 
positive expiratory pressure); 10 patients received medical therapy only (control group). 
Both treatments (traditional CPT and HFCWO) showed a significant improvement in 
some biochemical and functional respiratory tests as well as in the quality of life 
compared to the control group. The HFCWO technique provides an improvement both in 
pulmonary function and quality of life related parameters in patients with chronic 
hypersecretive disease.  
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9. Bita Rabbani, KatayoonNajafizadeh, et al (2013) 
The aim of this study was to evaluate the effect of halotherapy on pulmonary 
function tests and quality of life of non-CF bronchiectatic patients.This clinical trial 
evaluated the results of spirometry and 6-minute walk test as well as the quality of life 
(according to SF-36 questionnaire) of stable non-CF bronchiectatic patients presenting to 
the pulmonary clinic before and after the use of salt spray for 2 months.Of 40 study 
patients, 20 were excluded due to various reasons and 20 were evaluated. The mean age 
of patients was 35±11 years and the underlying cause of disease was chronic pulmonary 
infection in 65% of cases, patients were satisfied with halotherapy and requested to 
receive the medication again. Our study results indicated that 2-month halotherapy with 
Salitair inhaler containing salt crystals extracted from the Klodawa mine in Poland could 
not improve the pulmonary function tests or quality of life of non-CF bronchiectatic 
patients.  
10.Santamato A, Ranieri M, Panza F, Frisardi V, Marvulli R, Filoni S, Cisari 
C, Fiore P (2012) 
This study has been conducted for Pulmonary rehabilitation patients 
with bronchiectasis. It evaluated the efficacy of PR in the management of bronchiectasis. 
PR program consisting in treadmill walking, cycle ergometry, breathing exercises, 
and postural drainage with clapping percussion-vibratory-shaking . The significant 
improvements  in both exercise capacity and health status observed at the end of the PR 
program. 
11. Susan D Hanekom, Dina Brooks, Linda Denehy, Monika Fagevik-Olsén, 
Timothy C Hardcastle, ShamilaManie, and QuinetteLouw (2012) 
Postoperative pulmonary complications remain the most significant cause of 
morbidity following open upper abdominal surgery despite advances in preoperative care. 
The objective was to develop a clinical management algorithm for the post operative 
management of abdominal surgery patients. Eleven draft algorithm statements extracted 
from the extant literature by the primary research team were verified and rated by 
scientist clinicians (n = 5) in an electronic three round Delphi process. An expert Delphi 
panel interpreted the equivocal evidence for the physiotherapeutic management of 
15 
 
patients following upper abdominal surgery. Through a process of consensus a clinical 
management algorithm was formulated. 
12. IndranilChakravorty,KamaljitChahal, and Gillian Austin (2011) 
A randomized controlled crossover pilot study of HFCWO compared with 
conventional treatment was conducted in 22 patients with moderate to severe COPD and 
mucus hypersecretion. Sputum production showed a declining trend in the HFCWO 
phase, although not reaching statistical significance. The HFCWO device was well 
tolerated with good reported compliance.This pilot study demonstrated that patients with 
advanced COPD and mucus hypersecretion at increased risk of declining lung function 
tolerated the HFCWO treatment well, leading to improvement in quality of life and 
reduced symptoms. 
13. Valentina Fainardi,a Francesco Longo,a Silvia Faverzani, et al (2011) 
  The study was to compare the short-term efficacy of high-frequency chest 
compression and positive expiratory pressure mask on expectorated sputum, pulmonary 
function, and oxygen saturation in patients with CF hospitalized for an acute pulmonary 
exacerbation. Thirty-four CF patients (26 ± 6.5 years) were included in the study. Before 
and 30 minutes after each treatment were recorded: pulmonary function testing, oxygen 
saturation, and perceived dyspnea. High-frequency chest compression and positive 
expiratory pressure mask have comparable short-term effects on expectorated sputum and 
lung function. Although positive expiratory pressure mask was associated with a lower 
SpO2, it was better tolerated than high-frequency chest compression. 
14. Leyla P Osman, Michael Roughton, Margaret E Hodson, and Jennifer A Pryor 
(2010) 
High frequency chest wall oscillation (HFCWO) is standard treatment for airway 
clearance in the USA and has recently been introduced in the UK and Europe. The aim of 
this study was to compare the short-term effects of HFCWO with usual ACTs in patients 
with cystic fibrosis hospitalised with an infective pulmonary exacerbation.During both a 
finite treatment period and over 24 h, less sputum was cleared using HFCWO than usual 
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ACT. HFCWO does not appear to cause any adverse physiological effects and may 
influence adherence. 
15.McIlwaine M, Wong LT, Chilvers M, Davidson GF (2010)  
This study describes the  Long-term comparative trial of two 
different physiotherapy techniques; postural drainage with percussion and 
autogenic drainage, in the treatment of cystic fibrosis. Thus the various airway clearance 
techniques have been introduced for the treatment of cystic fibrosis. It was hypothesized 
that autogenic drainage, and airway clearance technique would be as effective as postural 
drainage with percussion in treating patients with CF. Results suggest that both  autogenic 
drainage and postural drainage are effective methods of performing physiotherapy for 
cystic fibrosis patients. 
16. Farley AH, Hendry C, Johnstone CC (2008)   
This study Reveals the pathophysiology, presentation and management. 
Bronchiectasis, although not as common as other respiratory disorders, can be life-
limiting and remains a significant problem for many patients.It examines the 
pathophysiology and presentation of bronchiectasis and identifies various management 
strategies. 
17. C Thompson, S Harrison, J Ashley, K Day, and D Smith (2002) 
A randomised crossover study was performed in 17 stable patients with non-cystic 
fibrosis bronchiectasis at home, in which 4 weeks of daily active cycle of breathing 
technique (ACBT) were compared with 4 weeks of daily physiotherapy with the Flutter 
device. A questionnaire indicated subjectively that patients preferred the Flutter (11/17) to 
ACBT for routine use.Daily use of the Flutter device in the home is as effective as ACBT 
in patients with non-cystic fibrosis bronchiectasis and has a high level of patient 
acceptability. 
18.Singleton R, Morris A, Redding G, Poll J, Holck P, Martinez P, Kruse D, Bulkow 
LR, Petersen KM, Lewis C.(2000) 
It  reviewed case histories of 46 children with bronchiectasis, observed that 
recurrent pneumonia was the major preceding medical condition in 85% of patients. 
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Itconclude that the continued high prevalence of bronchiectasis appears to be related to 
extremely high rates of infant and childhood pneumonia.  
19. S. Miller, D. O. Hall, C. B. Clayton, and R. Nelson (1995) 
In this study autogenic drainage was compared with the active cycle of breathing 
techniques (ACBT) together with postural drainage.Eighteen patients with cystic fibrosis 
took part in a randomised two-day crossover trial. There were two sessions of one method 
of physiotherapy on each day, either autogenic drainage or ACBT. Both methods 
improved ventilation, autogenic drainage was found to be as good as ACBT at clearing 
mucus in patients with cystic fibrosis and is therefore an effective method of home 
physiotherapy. Patients with cystic fibrosis should be assessed as to which method suits 
them best 
20. R Polosa, AHasani, D Pavia, J E Agnew, C K Lai, S W Clarke, and S T Holgate 
(1992) 
To evaluate this possibility the effect of inhaled bradykinin on mucociliary 
clearance has been studied in 10 healthy volunteers. Subjects attended the laboratory on 
two occasions to take part in tracheobronchial clearance studies using a non-invasive 
radioisotopic technique. Inhalation of radioaerosol was followed 30 minutes later by 
inhalation of either bradykinin (8 mg/ml) or vehicle placebo in a randomised, double 
blind fashion. After each inhalation the number of coughs was recorded. The median 
values (range) for AUC0-6h were significantly reduced from 126% (78-232%)/h with 
placebo to 87% (51-133%)/h with bradykinin. It is concluded that acute exposure to 
inhaled bradykinin accelerates tracheobronchial clearance in normal human airways. 
21. J A Pryor, B A Webber, and M E Hodson (1990) 
Decreasing arterial oxygen saturation has been reported in patients with cystic 
fibrosis during postural drainage when this was combined with other manoeuvres.When 
these features were included in an active cycle of breathing techniques during postural 
drainage in 20 patients with cystic fibrosis there was no fall in arterial oxygen saturation 
during the procedure (mean values 87.1%, 87.9%, and 86.7% before, during, and after 
treatment). 
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22. C P van der Schans, D A Piers, and D S Postma (1987) 
The effect of manual percussion of the thorax in nine patients with stable chronic 
airflow obstruction and excessive tracheobronchial secretion. Tracheobronchial clearance 
was measured over 50 minutes on three different days. It is apparent that manual 
percussion is a relatively ineffective procedure in patients with stable chronic airflow 
obstruction, but may be useful when the patient is not able to cough and cannot assume 
the appropriate position for postural drainage. 
23. J L Hofmeyr, B A Webber, and M E Hodson (1986) 
Three treatment regimens were compared in 18 patients with cystic fibrosis. 
Treatment A consisted of breathing exercises emphasising inspiration, interspersed with 
the forced expiration technique in gravity assisted positions; treatment B comprised 
breathing exercises with positive expiratory pressure alternating with the forced 
expiration technique in the same gravity assisted positions; and treatment C comprised 
breathing exercises with positive expiratory pressure and the forced expiration technique 
in the sitting position. There were no significant differences in arterial oxygen saturation, 
FEV1 or forced vital capacity. Sputum clearance was less effective when positive 
expiratory pressure was included in the treatment regimen. 
24.Mazzocco MC, Owens GR, Kirilloff LH, Rogers RM (1985)  
The study of Chest percussion and postural drainage in patients 
with bronchiectasis. It i to determine the effects of chest physical therapy on pulmonary 
function, arterial oxygenation, and sputum production and to assess whether this therapy 
was associated with any significant side-effects. It is found that chest physical therapy 
was safe and well tolerated and assisted the patients in mobilization of their sputum.  
25. J A Pryor, B A Webber, M E Hodson, and J C Batten (1979) 
Sixteen patients with cystic fibrosis were treated with conventional physiotherapy 
aided. The results were compared with those produced by physiotherapy using the forced 
expiration technique cleared more sputum in less time than conventional physiotherapy. 
A sputum in less time than conventional physiotherapy. The forced expiration technique 
might also be helpful for patients with chronic bronchitis, asthma, or bronchiectasis. 
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CHAPTER-3 
MATERIALS AND METHODOLOGY 
3.1  MATERIALS  
 Treatment couch 
 Treatment chair 
 Towel 
 Stop clock 
 Stethescope 
 B.P Apparatus  
 
3.2 METHODOLOGY 
 All patients underwent a cardio examination and posture evaluation. 
 CT Lungs and X ray shows the severity of Bronchiectasis. 
 PFT and Pulse Oxymeter is conducted to know how the patients affected                            
with Bronchiectasis. 
3.3 POPULATION 
 Patients with age group of 30-60 years having severity of Bronchiectasis. 
3.4 CRITERIA FOR SAMPLE SELECTION   
3.4 (a) INCLUSION CRITERIA 
 Both genders. 
 Age group between 30-60 years. 
 Sufficient hearing and vision. 
 Cases of isolated bronchiectasis. 
 Unilateral lung invovlvement 
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3.4 (b)  EXCLUSION CRITERIA 
The exclusion Criteria were conditions with symptoms of raised intra cranial 
pressure, Head and neck injury until stabilized, Active haemorrhage with hemodynamic 
instability, Recent spinal surgery (e.g., Laminectomy) or acute spinal injury, active 
haemoptysis, Empyema, Broncho pleural fistula, Pulmonary oedema associated with 
congestive heart failure, Large pleural effusions, pulmonary embolism, Aged, confused, 
or anxious patients who do not tolerate position changes, Rib fracture, with or without 
flail chest, Tumours, Active cases of tuberculosis. 
3.5 SOURCE OF DATA 
 SIMS Hospital,Erode. 
 KMCH Hospital,Erode. 
 DHANVANTHRI Hospital,Erode. 
3.6 SAMPLE SIZE 
 Sample size is 30 subjects 
 Group A-15 patients 
 Group B-15 patients 
3.7  STUDY DESIGN 
 Quasi Experimental design 
 Pre and Post experimental Study Design  
3.8 SAMPLING METHOD 
 Convenient  Sampling Method 
3.9 DURATION OF THE STUDY 
 The total duration of the study is 6 Months. 
3.10 TREATMENT DURATION 
Active cycle of  breathing technique for 15 - 20 minutes. Each standardized 
ACBT cycle lasted around two minutes. Three treatment sessions in a day were given 
with an interval of four hours between each session. 
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3.11  PARAMETER 
 Pulmonary Function Test 
 Pulse Oxymetry 
          VARIABLES 
 Forced Vital Capacity (FVC) 
 Forced Expiratory Volume in one second (FEV1)  
 Peak Expiratory Flow Rate (PEFR)  
 Pulse Oxymetry 
 
3.12 PROCEDURE 
The subjects were explained about the treatment, experimental procedures and 
outcome measures. Formal written consent was obtained from each subject and ethical 
clearance was obtained from Institutional Ethical Committee of PPG College of 
Physiotherapy. The selected 30 subjects were then randomly assigned to any of the two 
experimental treatment groups i.e. Group A and Group B of 15 subjects each. Group A, 
received Active cycle of breathing technique for 15 - 20 minutes. Each standardized 
ACBT cycle lasted around two minutes. During the study the total number of ACBT 
cycle performed during the treatment phase was individualized and not set. Three 
treatment sessions in a day were given with an interval of four hours between each 
session. Total study period was for eight hours. ACBT was administered to the affected 
lobe after explaining the procedure to the patients. Group B, have received postural 
drainage for 15–20 minutes. Three treatment sessions in a day were given with an interval 
of four hours between each session. Total study period was for eight hours and traditional 
postural drainage procedures were given to the affected lobes. The outcome tools used in 
the study were Pulmonary Function Test to measure Force Vital Capacity (FVC), Forced 
Expiratory Volume in one second (FEV1) and Peak Expiratory Flow Rate (PEFR) and 
Pulse Oxymetry was used to measure SPO2, which were done before administering the 
treatment and at the end of treatment for both the groups. 
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3.13 TECHNIQUES 
3.13 (a) ACTIVE CYCLE OF BREATHING 
 
People with a lung problems often cough and produce more phlegm (sputum) than 
is usual. It is important to remove sputum from your lungs to help you breathe more 
easily, prevent chest infections and reduce bouts of coughing. Leaving sputum in your 
chest can make your condition worse. 
The Active Cycle of Breathing Techniques (ACBT) is one way to help you to 
clear sputum from your chest. ACBT is a set of breathing exercises that loosens and 
moves the sputum from your airways. The ACBT exercises are breathing control, deep 
breathing and huffing which are performed in a cycle until your chest feels clear. 
Breathing Control                                                                                                                          
  Breathing control is breathing gently, using as little effort as possible. 
 Breathe in and out gently through your nose if you can. If you cannot,                    
breathe through your mouth instead  
 If you breathe out through your mouth you can use breathing control with 
„pursed lips breathing‟ 
  Try to let go of any tension in your body with each breath out 
  Gradually try to make the breaths slower 
  Try closing your eyes to help you to focus on your breathing and to relax 
It is very important to do Breathing Control in between the more active exercises of 
ACBT as it allows your airways to relax. Breathing control can also help you when you 
are short of breath or feeling fearful, anxious or in a panic.  
Deep Breathing Exercises 
Take a long, slow, deep breath in, through your nose if you can. Try to 
keep your chest and shoulders relaxed. Breathe out gently and relaxed, like a sigh. You 
should do 3-5 deep breaths. Some patients find it helpful to hold their breath for about 2-3 
seconds at the end of the breath in, before breathing out. Try the deep breathing exercises 
both with and without holding your breath and see which works best for you. 
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Huffing 
A huff is exhaling through an open mouth and throat instead of coughing. It helps 
move sputum up your airways so that you can clear it in a controlled way. To „huff‟ you 
squeeze air quickly from your lungs, out through your open mouth and throat, as if you 
were trying to mist up a mirror or your glasses. Use your tummy muscles to help you 
squeeze the air out, but do not force it so much that you cause wheezing or tightness in 
your chest. Huffing should always be followed by breathing control. There are 2 types of 
huff, which help to move sputum from different parts of the lungs.  
The Small-long huff 
This will move sputum from low down in your chest. Take a small to medium 
breath in and then huff (squeeze) the air out until your lungs feel quite empty, as detailed 
above.  
The Big-short huff 
This moves sputum from higher up in your chest, so use this huff when it feels 
ready to come out, but not before. Take a deep breath in and then huff the air out quickly. 
This should clear your sputum without coughing. 
 
Fig 3.1 ACTIVE CYCLE OF BREATHING 
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3.13(b) POSTURAL DRAINAGE 
Left Lower Lobe  
Lie on your right side with your head down and a pillow under your hips and legs.  
Percuss the left side from the armpit to the bottom of your ribs.  
Bend your left leg and rotate your body so your chest is pointing down.  
Percuss the back on the left side from shoulder blade to bottom of the ribs.  
 
 
 
 
Fig 3.2 POSTURAL DRAINAGE 
 
 
Right Lower and Middle Lobes  
Lie on your left side with your head down and pillows under your hips and legs.  
Percuss right side from the armpit to the bottom of the ribs.  
Bend your right leg and rotate your body so your chest is pointing down.  
Percuss the back on the right side from the shoulder blade to bottom of the ribs. 
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Right Lower and Middle Lobes 
  Lie on your left side with your head down and pillows under your hips and legs. 
Percuss right side from the armpit to the bottom of the ribs. 
  Bend your right leg and rotate your body so your chest is pointing down. 
Percuss the back on the right side from the shoulder blade to bottom of the ribs. 
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Right and Left Lower Lobes (Back) 
With this position you can drain and percuss both lower lobes at the same time. 
This position may be difficult for you if you have a trach or are on a ventilator. 
Lie face down with a pillow under your chest and stomach.  
Percuss on either side of the spine from the shoulder blade to the bottom of the             
ribs. 
 
 
 
Right and Left Upper Lobes (Back)  
Sit in a chair with a pillow in front of your stomach and lean forward.  
Percuss over the shoulder blades on both sides 
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Right and Left Upper Lobes (Front)  
Sit up in a chair with a pillow behind your back and lean back.  
Percuss over the upper part of both sides of the chest to the nipple.  
Percuss only to the top of the breasts in females. 
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CHAPTER-4 
 
DATA PRESENTATION AND STASTISTICAL ANALYSIS 
 
STATISTICAL TOOLS 
 The statistical tools used in the study are paired t-test and unpaired t-test. 
 
PAIRED 't'-TEST 
 The paired t-test was used to find out the statistical significance between pre and 
post t-test values of PFT  and Pulse Oxymetry before and after treatment for Group A and 
Group B. 
 
Formula for paired t-test, 
 
                                           S =
𝚺𝒅૛− (𝚺𝒅)૛𝒏𝒏−૚  
                                            t = 𝒅  𝒏𝒔  
 
d = difference between the pre test Vs post test  𝑑  = Mean difference  
n = Total number of subjects 
S = Standard deviation  
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UNPAIRED 't'- TEST 
 The unpaired t-test was used to compare the statistically significance difference of 
DHI and VAS before and after treatment for Group A and Group B. 
 
Formula for unpaired t –test, 
                                  S =  (𝒏૚−૚)𝒔૚૛+(𝒏૛−૚)𝒔૛૛𝒏૚+𝒏૛−૛  
                                  t =  𝒙 ૚−𝒙 ૛ 𝒔 ૚𝒏૚+ ૚𝒏૛ 
 
n1 = Total number of subject in group A. 
n2 = Total number of subject in group B. 
x1 = Difference between pre test and post test of Group A. 𝑥1      =          Mean difference between pre test and post test of group A. 
X2 = Difference between pre test and post test of Group B. 
X2 = Mean difference between pre test and post test of Group B. 
S = Standard Deviation. 
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MAIN RESULTS 
 Table 4.1 and Figure 4.1 shows the age distribution  among the study. The patients 
were in the range of 30-60 years. The mean average age of Group A and Group B were 
56.    
TABLE-4.1(MEAN AVERAGE AGE GROUP OF GROUP A AND GROUP B) 
 
Mean Age  Group Group A Group B 
Female’s 57 56 
Male’s 56 55 
 
 
                FIG-4.1(MEAN AVERAGE AGE OF GROUP A AND  GROUP B) 
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SEX DISTRIBUTION OF GROUP A AND GROUP B 
Table 4.2 and Figure 4.2 shows the sex distribution among the study.  There are 
60% of males and 40% of females in both Groups. 
                                                      TABLE-4.2 
Sex Distribution Group A Group B 
Male’s 10 9 
Female’s 5 6 
 
 
                 FIG 4.2 (SEX DISTRIBUTION OF GROUP A AND GROUP B) 
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SIDE  INVOLVEMENT BETWEEN GROUP A AND GROUP B 
 Table 4.3 and Figure 4.3 shows the information relating to the 
sideinvovlement among the patients in the study. The Group A consist of 9 right 
side lunginvolvement  patients and 6 left side lung involvement patients 
respectively. The Group B consists of 8 right side lung involvement patients and 7 
left side lung involvement patients.  Right Sided involvement  is statistically 
higher among  two group. 
 
                                                      TABLE-4.3 
Side Involvement Group A Group B 
Right Side 9 8 
Left Side 6 7 
 
 
        FIG-4.3 (SIDE INVOLVEMENT BETWEEN GROUP A AND GROUP B) 
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COMPARISON OF VARIABLES MEAN DIFFERENCE BETWEEN  GROUP A 
AND GROUP B OF  PFT AND PULSE OXYMETRY 
                                                    TABLE-4.4 
VARIABLES GROUP A  GROUP B 
FVC  83 77 
FEV1 80 77 
PEFR 209 197 
SPO2 98 94 
 
              FIGURE-4.4 (MEAN DIFFERENCE OF FVC, FEV1,PEFR AND SPO2)     
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COMPARISON OF VARIABLES STANDARD DEVIATION BETWEEN GROUP A 
AND GROUP B OF  PFT AND PULSE OXYMETRY 
 
                                                    TABLE-4.5 
VARIABLES GROUP A GROUP B 
FVC 1.26 1.06 
FEV1 2.93 1.69 
PEFR 3.51 3.13 
SPO2 1.41 1.00 
 
       FIGURE-4.5 (STANDARD DEVIATION OF FVC, FEV1,PEFR AND SPO2 ) 
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COMPARISION OF THE PAIRED ‘t’ TEST AND TABLE VALUE BETWEEN 
GROUP A AND GROUP B 
  TABLE-4.6 
   GROUPS 
CALCULATED ' t'VALUE 
TABLE  VALUE SIGNIFICANCE GROUP A GROUP B 
FVC 250.31 175.20 2.15 SIGNIFICANT 
FEV1 
103.75 102.30 
2.15 SIGNIFICANT 
PEFR 
226.26 196.85 
2.15 SIGNIFICANT 
SPO2 
263.30 246.50 
2.15 SIGNIFICANT 
   
FIGURE-4.6 (PAIRED ‘t’ TEST AND TABLE VALUE OF FVC, FEV1,PEFR AND                  
SPO2) 
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COMPARISION OF UNPAIRED ‘t’ TEST AND TABLE VALUE BETWEEN PFT 
AND PULSE OXYMETRY 
                                                                 TABLE-4.7 
VARIABLES UNPAIRED ‘t’ TEST TABLE  VALUE SIGNIFICANCE 
FVC 36.45 2.05 SIGNIFICANT 
FEVI 10.71 2.05 SIGNIFICANT 
PEFR 10.92 2.05 SIGNIFICANT 
SPO2 8.88 2.05 SIGNIFICANT 
 
FIGURE- 4.7 (UNPAIRED ‘t’ TEST AND TABLE VALUE FOR FVC, FEV1,PEFR                         
AND SPO2) 
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CHAPTER-5 
RESULTS AND DISCUSSION 
5.1 RESULTS 
The study sample comprised 30 patients, of which 15 were male and 15 were 
female. The mean age of patients was 56 years.   Among 30 patients, 15 were treated with 
ACBT, and 15 were treated with Postural drainage.   
 The pre and post test values were assessed by PFT  and Pulse Oxymetry in group A 
and group B. The mean difference value of FVC is 83 and 77, FEV1 is 81 and 77, PEFR 
is 209 and 197 and SPO2 is 98 and 94 respectively. The standard deviation  of FVC is 
1.26 and 1.06, FEV1 is 2.93 and 1.69, PEFR is 3.51 and 3.13 and SPO2 is 1.41 and 1.00 
respectively.The paired „t‟ test value of FVC is 250.31 and 175.20, FEV1 is 103.75 and 
102.30, PEFR is 226.26 and 196.85 and SPO2 is 263.30 and 246.50 respectively. The 
paired „t‟  test value is more than table value 2.15 for 5% level of significance at 14 
degrees of freedom. 
The calculated „t‟  values by unpaired „t‟  test of  FVC is 36.45, FEV1 is 10.71, 
PEFR is 10.92 and SPO2 is 8.88 respectively The calculated „t‟  values were more than 
the table value 2.05 for 5% level of significance at 28 degrees of freedom. 
The paired  „t‟  test values have shown that ACBT  was more effective than Postural 
Drainage in improving airway clearance in patients with Bronchiectasis.. The unpaired „t‟  
test values have shown that there was significant difference between two groups in 
showing improvement in their quality of life in  patients with Bronchiectasis. 
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5.2  DISCUSSION 
This was a comparative study between effectiveness of Active Cycle of Breathing 
Technique and Postural Drainage for improving pulmonary function in bronchiectasis 
patients. The results shows that, Active Cycle of Breathing Technique is having better 
effect on clearing the airways in bronchiectasis patients compared with postural drainage. 
The result of the study supports the hypothesis that there will be a significant effect in 
airway clearance in bronchiectasis patients using both Active cycle of breathing technique 
and postural drainage but when both the techniques are compared ACBT is having a 
better effect than Postural Drainage to improve pulmonary function in Bronchiectasis. In 
a study by Patterson et al in their article stated that, ACBT is a more effective method of 
airway clearance in bronchiectasis during single treatment sessions. Other study by Pryor 
et al  in their study stated that, a decrease in oxygen saturation caused by chest percussion 
may be avoided by using the ACBT technique. Similar findings were found in studies 
done by Savci S et al who stated that ACBT is effective in cleaning secretions and 
improving lung functions in Bronchiectasis. The ACBT increased forced vital capacity, 
peak expiratory flow rate, arterial oxygenation and exercise performance. 
Majority of the patients selected in this study reported to have an earlier medical 
history of infective disease such as Tuberculosis, Post necrotizing pneumonia etc. 
Bronchiectesis is one of the most common types of COPD secondary to any other 
infective diseases. There was an earlier study done by E Silverman et al  who stated in 
their study that, known causative factors include post infection bronchial damage, post 
inhalation injury, hypersensitivity reactions, and congenital airway obstructive disorders. 
One interesting observation made during this study was about the higher quantity of the 
secretion removed in the early morning treatment session compared with the other 
treatment sessions the patient had in the same day which may be because it is done for the 
first time after a gap of 8-10 hours of previous treatment session. This was also noted by 
Willy E. Hammon and Scot Hasson earlier. As per the pathology stated by earlier 
researchers, that bronchiectasis usually affects the lower lobes of the lung, and mostly 
unilateral, same distribution of affection were observed in this study too. Majority of the 
cases selected for this study, that‟s nearly 65% were affected with unilateral 
bronchiectasis. The same findings were found in prior studies done by Willy E. Hammon 
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and Scott Hasson stated Bronchiectasis usually localized in a few segments or in entire 
lobe of the lung. Most commonly, it is unilateral and effects basal segments of the lower 
lobes. There are significant changes seen in FVC, PEFR and FEV1 in this study after the 
intervention of both ACBT and Postural Drainage in bronchiectasis and this findings were 
supported by J.A. Pryor  who stated that there is evidence of an improvement in lung 
function; including FEV1, FVC and maximum expiratory flow rate at 25% and 50% of 
FVC following the instigation of the ACBT. There is a need for adequately sized, high-
quality, randomized controlled trials with uniform patient populations to examine the 
effects of ACBT and Postural Drainage in Bronchiectasis.   
 
  5.3   LIMITATIONS 
 
 The study has been conducted on small sized sample only. 
 This study took shorter duration to complete. 
 The study limitations include only Bronchiectasis patients alone. 
 
 
5.4  RECOMMENDATIONS 
 A similar study may be extended with larger sample. 
 The future study can be compared with percussion techniques also. 
 The ACBT may be applied to the other COPD conditions also. 
 This ACBT may be compared with breathing exercises also. 
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CHAPTER-6 
SUMMARY AND  CONCLUSION 
 Even though both ACBT and Postural Drainage techniques are found to have significant 
effect in clearing the airways, the Active cycle of breathing technique has a better effect than the 
postural drainage and thereby improving pulmonary function in patients with bronchiectasis. 
  Through the results, alternate hypothesis is accepted and also the study 
could be concluded that there is a significant difference between active cycle of 
breathing technique and postural drainage in patients with bronchiectasis. 
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 APPENDIX –I 
ASSESSMENT PERFORMA 
 
 
PERFORMA FOR DATA COLLECTION   
A. PERSONAL DETAILS 
1. Name    : 
2. Age    : 
3. Sex    : 
4. Occupation   : 
5. Father‟s/Mother‟s name :     
6. I.P. No. /O.P. No  :  
7. Date    : 
8. Address   :  
9. Cheif Complaints  : 
B. HISTORY OF PRESENT ILLNESS AND REVIEW OF SYSTEMS  
General  
The following characteristics of each symptom should be elicited and explored:   
 Onset – sudden or gradual 
 Location – radiation 
 Duration – frequency, chronology 
 Characteristics – quality, severity 
 Aggravating and precipitating factors 
 Relieving factors 
 Current situation (improving or deteriorating) 
 Effects on Activities of Daily Living (ADL) 
 Previous diagnosis of similar episodes 
 Previous treatments and efficacy 
          Cardinal Signs and Symptoms 
 In addition to the general characteristics outlined above, additional characteristics 
of specific symptoms should be elicited, as follows:  
 Cough   
 Quality 
 Severity 
 Timing 
 Duration: greater than 2 weeks (screen for Tuberculosis (TB) 
     Sputum   
 Colour 
 Amount 
 Consistency 
 Purulence, odour, foul taste 
 Time of day, worse 
       Haemoptysis   
 Amount of blood 
 Frank blood or mixed with sputum 
 Association with leg pain, chest pain, shortness of breath 
         Shortness of Breath   
 Exercise tolerance (number of stairs client can climb or distance client can 
walk) 
 Posture – orthopnea or tripoding 
 Shortness of breath at rest 
 Association with Paroxysmal Nocturnal Dyspnea (PND) 
 Associated swelling of ankles or recent weight gain 
    Cyanosis   
 Central vs peripheral 
 When does it occur 
 Any recent changes in pattern of 
 Associated wheeze 
 
  
         Chest Pain  
 Associated symptoms  
 Relation to effort, exercise, meals, bending over 
 Explore the pain carefully – include quality, radiation, severity, timing 
   Fainting or Syncope   
 Weakness, light-headedness, loss of consciousness 
 Relation to postural changes, vertigo or neurological symptom 
     Extremities   
 Edema: 
                           - site 
                           – relation of edema to activity or time of day   
 Intermittent claudication (exercise-induced leg pain) 
                           - distance client can walk before onset of pain related to claudication  
                           - time needed to rest to relieve claudication  
                           - temperature of affected tissue (warm, cool or cold)   
 Tingling 
 Leg cramps or pain at rest 
 Presence of varicose veins 
         Other Associated Symptoms 
 Fever 
 Malaise 
 Fatigue 
 Night sweats 
 Weight loss 
 Palpitations 
  Nausea and vomiting 
 Gastro intestinal reflux 
C. MEDICAL HISTORY SPECIFIC TO CARDIO-RESPIRATORY SYSTEMS  
 Allergies, including seasonal and environmental 
 Medications currently used (prescription and Over The Counter (OTC) e.g., 
angiotensinconverting 
 enzyme (ACE) inhibitors, ß-blockers, (acetylsalicylic acid or ASA), steroids, nasal 
sprays and inhaled medications (puffers), antihistamines, hormones, diuretics, 
antacids, steroids, digoxin)   
 Herbal/traditional preparations 
 Immunizations (e.g., pneumococcal, annual influenza) 
 Medical conditions:  
- Frequency of colds and respiratory infections, recent viral illness, joint pain or 
swelling 
 - History of rheumatic fever  
- Nasal polyps, chronic sinusitis, asthma, bronchitis, pneumonia, chronic obstructive 
pulmonary disease (COPD), TB (disease or exposure), cancer, cystic fibrosis  
- Dyslipidemia, hypertension, diabetes mellitus, thyroid disorder, chronic renal 
disease, systemic lupus erythematosus  
- Coronary artery disease (CAD), angina, myocardial infarction (MI)  
- Cardiac murmurs, valvular heart disease 
 - Down‟s Syndrome  
 Date and result of last Mantoux test and chest x-ray 
 Admissions to hospital and/or surgery for respiratory or cardiac illness 
 Blood transfusion 
 Family History (Specific to Cardio-respiratory Systems) 
Family History (Specific to Cardio-respiratory Systems)   
 Others at home with similar symptoms 
 Allergies, atopy 
 Asthma, lung cancer, TB, cystic fibrosis, bronchitis 
 Diabetes mellitus 
  Heart disease: hypertension, ischemic coronary artery disease, MI (especially in 
family members < 50 years of age), sudden death from cardiac disease, dyslipidemia, 
hypertrophic cardiomyopathy 
 Personal and Social History (Specific to Cardio-respiratory Systems)   
 Smoking history (number of packages/day, number of years) 
 Exposure to second hand smoke, wood smoke, pets, mould 
 Crowded living conditions 
 Poor personal or environmental cleanliness 
 High stress levels (personal or occupational) 
 Institutional living  Occupational or environmental exposure to respiratory irritants 
(mining, forest fire fighting) 
 Substance use (e.g., alcohol, caffeine, street drugs, including injection and inhaled 
drugs / solvents)  
 Human immunodeficiency virus (HIV) risks 
 Obesity 
 Immigration or travel abroad 
D. PHYSICAL ASSESSMENT 
 Examination of the ear, nose, and throat should also be carried out because of the 
interrelatedness between these systems and structures and the functioning of the lower 
respiratory tract. 
Vital Signs  
 Temperature 
 Pulse 
 Respiratory rate 
 SpO2 
 Blood pressure (BP) 
 Peak flow 
  
 
 General Appearance   
 Acutely or chronically ill 
 Degree of comfort or distress 
 Position to aid respiration (e.g., tripod) 
 Diaphoresis 
 Ability to speak a normal-length sentence without stopping to take a breath 
 Colour 
 Nutritional status 
 Hydration status 
 Mental staus 
Inspection   
 Colour, cyanosis 
 Shape of chest 
 Symmetry of chest movement 
 Rate, rhythm and depth of respiration, respiratory distress 
 Intercostal indrawing 
 Use of accessory muscles 
 Precordium: visible pulsations 
 Chest wall scars, bruising, signs of trauma 
 Jugular venous pressure (JVP) 
 Color of conjunctiva 
 Extremities 
 Hands – edema, cyanosis, clubbing, nicotine stains, cap refill 
- Feet and legs – changes in foot color with changes in leg position i.e., blanching 
with elevation, rubor with dependency, ulcers, varicose veins, edema (check sacrum if client 
is bedridden), colour (pigmentation, discoloration), distribution of hair  Skin – rashes, lesions,  
 Xanthomas 
 
 
 Palpation   
 Tracheal position (midline) 
 Chest wall tenderness or crepitus 
 Respiratory excursion 
 Tactile fremitus 
 Spinal abnormality 
 Nodes (axillary, supraclavicular, cervical) 
 Masses 
 Apical beat 
 - Point of maximum impulse (PMI) normally located at the fifth intercostal space, 
midclavicular line - Assess quality and intensity of apical beat  
- Apical beat (PMI) may be laterally displaced, which indicates cardiomegaly  
 Identify and assess pulsations and thrills 
 Hepatomegaly, right upper quadrant (RUQ) tenderness 
 Assess peripheral pulses  
– radial, brachial, femoral, popliteal, posterior tibial, dorsalis pedis 
 - Check for synchrony of radial and femoral pulses  
 Edema: pitting (rated 0 to 4) and level (how far up the feet and legs the edema 
extends) sacral edema 
Percussion of lung fields  
 Resonance 
 - Increased resonance over hyperinflated areas 
  - Dullness to percussion over areas of consolidation  
- Location and excursion of the diaphragh 
 
 
 Auscultation of lungs  
 Listen for sounds of normal air entry before trying to identify abnormal sounds 
 Degree of air entry throughout the chest (should be equal) 
 Quality of breath sounds (e.g., bronchial, bronchovesicular, vesicular) 
 Ratio of inspiration to expiration 
 Adventitious sounds: 
 Wheezes (rhonchi), crackles (rales), pleural rub, stridor, decreased breath sounds. 
Auscultation of heart  
 Listen to normal heart sounds before trying to identify murmurs 
 Auscultate at aortic, pulmonic, Erb‟s point, tricuspid, and mitral. Attempt to identify: 
- Rate and rhythm 
- S1 and S2 sounds and their intensity  
- Added heart sounds (S3 and S4), rubs, splitting of S2 
-murmur 
- Auscultate carotid arteries, abdominal aorta, renal arteries, iliac                  
arteries, and femoral arteries for bruits  
Associated Systems   
A complete respiratory assessment includes the Ear, Nose and Throat (ENT) system 
  Consider Gastro Intestinal (GI)/Genito-Urinary (GU) assessment if appropriate 
 
E. DIAGNOSTIC TESTS 
F. TREATMENT 
 ACBT 
 Postural-Drainage  
 
 
 APPENDIX-II 
ETHICAL CLEARANCE 
 
 
 
Ethically permission for the study will be obtained from the subjects and a 
written consent will be taken from each subject who participates in the study, As this 
study involve human subjects the Ethical Clearance has been obtained from the 
Ethical committee of PPG college of Physiotherapy, Coimbatore as per the Ethical 
guidelines for Bio-medical research on human subjects, 2000 ICMR, (Indian Council 
of Medical Research) New Delhi.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 PPG COLLEGE OF PHYSIOTHERAPY, 
COIMBATORE. 
 
Informed consent form for the volunteers at “PPG college of Physiotherapy, 
Coimbatore”, who will be participating in the research project entitled: “EFFICACY OF 
ACTIVE CYCLE OF BREATHING TECHNIQUE AND POSTURAL DRAINAGE IN 
PATIENTS WITH BRONCHIECTASIS - A COMPARATIVE STUDY.”  
Name of Principal Investigator 271430202 
Post graduate student 
Name of Organization Department of Physiotherapy,  
PPG college of Physiotherapy, Coimbatore. 
 
This Informed Consent Form has two parts: 
 Information Sheet (to share information about the research with you) 
 Certificate of Consent (for signatures if you agree to take part) 
 You will be given a copy of the full Informed Consent Form 
 
 
 
 
  
 PART I: Information Sheet 
Introduction 
I, ____________, Postgraduate student in the Department of Physiotherapy, PPG college of 
Physiotherapy, Coimbatore, am working on my dissertation titled “EFFICACY OF 
ACTIVE CYCLE OF BREATHING TECHNIQUE AND POSTURAL DRAINAGE IN 
PATIENTS WITH BRONCHIECTASIS - A COMPARATIVE STUDY”. 
   I am going to give you information and invite you to be part of this research. 
You do not have to decide today whether or not you will participate in the research. Before 
you decide, you can talk to anyone you feel comfortable with about the research.  
 There may be some words that you do not understand. Please ask me to stop as 
we go through the information and I will take time to explain. If you have questions later, 
you can ask them and get yourself clarified. 
Type of Research Intervention 
In this study if you are selected, detailed history taking, clinical examination and 
routine investigations will be done. 
Participant selection 
 Study group: Adult between age groups of 30-60 years presenting with history of brief 
history of Bronchiectasis. 
 
Procedures and Protocol 
  Thirty patients who are between 30-60 years with Bronchiectasis will be recruited in 
study group after obtaining the informed consent. Detailed history, clinical examination and 
routine blood investigation will be done.  After explaining the procedure all the patients will 
bedivided into 2 study groups each study group consisting of atleast 15patients. First study 
group will be treated with ACBT. Second study group with Postural Drainage and outcome 
will be done for each study group at the end of treatment session. The data will be analysed 
statistically.  
Duration: 6 months  
 Voluntary Participation 
Your participation in this research is entirely voluntary. It is your choicewhether you 
choose to participate or not, it will not affect our patient‟s treatment process. 
Benefits  
  Personally you might be or may not be benefited in any way directly from the 
research. But by taking part in this research, you will be helping the scientific 
community. 
Possible risks 
 There are no major physical risks for the person associated with these 
methods.  Complications include exacerbation of symptoms after maneuver which is 
rare possibility. 
Reimbursements 
 You won‟t be given any monetary incentives or gifts for being a part of this research. 
Confidentiality 
 The information that we collect from this research project will be kept 
confidential. Information about the patient that will be collected during the research will be 
put away and no-one but the researchers will be able to see it.  
Right to Refuse or Withdraw 
 You do not have to take part in this research if you do not wish to do so. You 
may also stop participating in the research at any time you choose. It is your choice and all 
of your rights will still be respected. 
Who to Contact 
  This proposal has been reviewed and approved by the Research and Ethical 
committee of PPGCollege of Physiotherapy, Coimbatore, which is a committee whose task it 
is to make sure that research participants are protected from harm.  
  You can ask me any more questions about any part of the research study, if 
you wish to. Do you have any questions?  
 PART II: Certificate of Consent 
 I have read the foregoing information, or it has been read to me. I have been explained 
the procedure and complications. I am willing to participate in the study. I have had the 
opportunity to ask questions about it and any questions that I have asked have been answered 
to my satisfaction. I consent voluntarily to participate as a participant in this research.  
Name of Participant_________________________      
Signature of Participant ___________________ 
Date __________________________________Day/month/year   
     
If illiterate a literate witness must sign (if possible, this person should be selected by 
the participant and should have no connection to the research team). Participants who are 
illiterate should include their thumb-print as well.   
I have witnessed the accurate reading of the consent form to the potential participant, 
and the individual has had the opportunity to ask questions. I confirm that the individual has 
given consent freely.  
Name of witness_________________                    Thumb print of participant 
 
 
Signature of witness _____________ 
 
Date _______________________ 
 
 
 
 
 
 Statement by the researcher/person taking consent 
         I have accurately read out the information sheet to the potential participant, and to 
the best of my ability made sure that the participant understands that the following will be 
done: 
      1. Blood investigations: 
 Hb, TC, DC, ESR, RBS, Serum electrolytes, Blood Urea and Serum   
Creatinine. 
2.  PFT. 
3.  Postural Drainage. 
 I confirm that the participant was given an opportunity to ask questions about the 
study, and all the questions asked by the participant have been answered correctly and to the 
best of my ability. I confirm that the individual has not been coerced into giving consent, and 
the consent has been given freely and voluntarily.  
A copy of this informed consent from has been provided to the participant. 
 
Name of Researcher/person taking the consent________________________   
    
Signature of Researcher /person taking the consent_____________________ 
Date ___________________________ Day/month/year  
 
 
 
 
 
 
  
 APPENDIX - III 
GROUP-A 
 
S.No Age Sex 
FVC FEV1 PEFR SPO2 
Pre 
test 
Post 
test 
Pre 
test 
Post 
test 
Pre 
test 
Post 
test 
Pre 
test 
Post 
test 
1. 
57 M 72 82 65 80 160 210 90 96 
2. 
57 M 74 84 66 82 165 205 91 97 
3. 
57 F 73 83 68 84 170 215 92 98 
4. 
56 M 75 85 70 80 175 215 93 100 
5. 
57 F 71 81 67 77 160 205 94 98 
6. 
57 M 73 83 69 85 175 215 95 100 
7. 
56 M 75 85 69 85 165 205 95 100 
8. 
57 F 74 84 67 77 155 205 94 98 
9. 
57 F 72 84 70 80 160 205 95 100 
10. 
57 F 71 82 65 76 165 210 92 98 
11. 
56 M 72 82 66 82 155 205 91 98 
12. 
57 M 70 82 67 80 175 215 92 100 
13. 
57 M 75 85 65 76 165 205 95 100 
14. 
56 M 73 83 66 82 160 210 90 98 
15 
56 M 71 82 69 81 175 215 94 100 
 
 
    F- Female 
    M-Male 
 APPENDIX - IV 
GROUP-B 
 
S.No Age Sex FVC FEV1 
PEFR SPO2 
Pre 
test 
Post 
test 
Pre 
test 
Post 
test 
Pre 
test 
Post 
test 
Pre 
test 
Post 
test 
1. 56 M 65 75 69 79 175 190 94 95 
2. 56 M 66 76 66 76 160 195 95 96 
3. 55 M 70 77 65 75 165 190 94 95 
4. 56 F 64 78 66 76 155 195 94 95 
5. 56 F 67 77 67 77 165 195 92 94 
6. 55 M 64 76 69 79 175 200 91 93 
7. 56 F 70 78 70 80 170 195 90 92 
8. 55 M 65 75 70 78 160 200 90 93 
9. 55 M 67 77 69 79 165 195 95 96 
10. 56 F 64 78 65 75 170 195 92 94 
11. 56 F 65 76 66 76 155 195 91 93 
12. 56 F 64 77 65 75 160 200 92 96 
13. 55 M 70 78 69 79 165 200 93 94 
14. 55 M 64 76 70 78 165 200 95 95 
15. 56 M 67 77 68 78 160 200 94 95 
    F- Female 
    M-Male 
  
 ABSTRACT 
 
Aim:  
 The Aim of this study is to compare the Efficacy of Active Cycle of Breathing 
Technique and Postural Drainage in Patients with Bronchiectasis. 
Materials and Methodology:  
           A Quasi Experimental study design consiting of reviews of charts of Bronchiectasis 
patients. Thirty patients were included, (60%) were males,(40%) were females ; the average 
age was 56 years. All the patients are presented with unilateral lung involvement. Pre- and 
Post-Treatment scores of FVC, FEV1, PEFR and SPO2 are assessed to know their breathing 
capacity by Pulmonary Function test and Pulse Oxymetry. 
Results:  
          The pre and post test values were assessed by PFT and Pulse Oxymetry in group A and 
group B. The mean difference value of FVC is 83 and 77, FEV1 is 81 and 77, PEFR is 209 
and 197 and SPO2 is 98 and 94 respectively. The standard deviation  of FVC is 1.26 and 1.06, 
FEV1 is 2.93 and 1.69, PEFR is 3.51 and 3.13 and SPO2 is 1.41 and 1.00 respectively.The 
paired „t‟ test value of FVC is 250.31 and 175.20, FEV1 is 103.75 and 102.30, PEFR is 
226.26 and 196.85 and SPO2 is 263.30 and 246.50 respectively. The paired ‘t‟ test value is 
more than table value 2.15 for 5% level of significance at 14 degrees of freedom. 
The calculated ‘t‟ values by unpaired ‘t‟ test of  FVC is 36.45, FEV1 is 10.71, 
PEFR is 10.92 and SPO2 is 8.88 respectively The calculated „t‟ values were more than the 
table value 2.05 for 5% level of significance at 28 degrees of freedom. 
Conclusion:  
The paired „t‟  test values have shown that ACBT  was more effective than Postural 
Drainage in improving airway clearance in patients with Bronchiectasis. The unpaired „t‟  test 
values have shown that there was significant difference between two groups in showing 
improvement in their quality of life in  patients with Bronchiectasis. 
Keywords: 
       Pulmonary Function test, Pulse Oxymetry, Active Cycle of Breathing, Postural Drainage. 
